CCL19 and breast cancer: TNBC-derived soluble factors enhanced the CCL19 induced chemotaxis of mature DCs in a JNK signaling pathway dependent manner and generated inflammatory DCs which induce highly proliferative and less apoptotic inflammatory T cells, resulting in high inflammatory milieu, of which condition may be positively correlated with breast cancer progression33.